Results 221 to 230 of about 204,330 (266)
Some of the next articles are maybe not open access.
JAMA
This JAMA Insights Clinical Update discusses the diagnosis, treatment, prognosis, and infection-prevention measures for Candida auris.
Anastasia, Wasylyshyn, Emily K, Stoneman
openaire +3 more sources
This JAMA Insights Clinical Update discusses the diagnosis, treatment, prognosis, and infection-prevention measures for Candida auris.
Anastasia, Wasylyshyn, Emily K, Stoneman
openaire +3 more sources
Current Opinion in Infectious Diseases, 2018
Purpose of review To give an update on the recent emergence of Candida auris. Recent findings C. auris is a pathogen, that evades present therapeutic options, that is highly virulent, causes disease in all types of patients, and spreads easily in ...
Saris, K., Meis, J.F., Voss, A.
openaire +3 more sources
Purpose of review To give an update on the recent emergence of Candida auris. Recent findings C. auris is a pathogen, that evades present therapeutic options, that is highly virulent, causes disease in all types of patients, and spreads easily in ...
Saris, K., Meis, J.F., Voss, A.
openaire +3 more sources
Candida auris and Nosocomial Infection
Current Drug Targets, 2020The existence of the multi-drug resistant (MDR) pathogenic fungus, Candida auris came to light in 2009. This particular organism is capable of causing nosocomial infections in immunecompromised persons. This pathogen is associated with consistent candidemia with high mortality rate and presents a serious global health threat.
Sweety, Dahiya +7 more
openaire +2 more sources
Nature Communications
Invasive candidiasis affects 1.6 million people annually, with high mortality among immunocompromised and hospitalized patients. Echinocandins are frontline antifungals, but rising resistance limits their efficacy. Here, we show that Candida albicans and
Malitha C. Dickwella Widanage +10 more
semanticscholar +1 more source
Invasive candidiasis affects 1.6 million people annually, with high mortality among immunocompromised and hospitalized patients. Echinocandins are frontline antifungals, but rising resistance limits their efficacy. Here, we show that Candida albicans and
Malitha C. Dickwella Widanage +10 more
semanticscholar +1 more source
Nature Communications
The rise of drug-resistant fungal species, such as Candida auris, poses a serious threat to global health, with mortality rates exceeding 40% and resistance rates surpassing 90%.
Yuping Zhang +16 more
semanticscholar +1 more source
The rise of drug-resistant fungal species, such as Candida auris, poses a serious threat to global health, with mortality rates exceeding 40% and resistance rates surpassing 90%.
Yuping Zhang +16 more
semanticscholar +1 more source
Atazanavir Resensitizes Candida auris to Azoles
Antimicrobial Agents and Chemotherapy, 2023Candida auris represents an urgent health threat. Here, we identified atazanavir as a potent drug capable of resensitizing C. auris clinical isolates to the activity of azole antifungals.
Yehia Elgammal +2 more
openaire +2 more sources
Pathogens
Introduction: The epidemiology of candidemia has shifted in the past few decades; drug-resistant non-albicans Candida species have become more prevalent worldwide.
A. Pyrpasopoulou +11 more
semanticscholar +1 more source
Introduction: The epidemiology of candidemia has shifted in the past few decades; drug-resistant non-albicans Candida species have become more prevalent worldwide.
A. Pyrpasopoulou +11 more
semanticscholar +1 more source
Nature Communications
Candida auris is a fungal pathogen notorious for persistent skin colonization and transmission in healthcare settings. Here, we show that a C. auris conserved adhesin, Als4112, is required for skin colonization via keratinocyte attachment and direct ...
Guolei Zhao +24 more
semanticscholar +1 more source
Candida auris is a fungal pathogen notorious for persistent skin colonization and transmission in healthcare settings. Here, we show that a C. auris conserved adhesin, Als4112, is required for skin colonization via keratinocyte attachment and direct ...
Guolei Zhao +24 more
semanticscholar +1 more source
2022
Candida auris is an emerging but important pathogen due to its ability to cause epidemics and antifungal resistance. This factor, which was first detected in 2009, has rapidly started to be seen globally, and there have been cases detected in our country in recent years. However, much remains unknown about this current global public health pathogen. In
KARAAYVAZ, Serhat, ALKAN, Sevil
openaire +1 more source
Candida auris is an emerging but important pathogen due to its ability to cause epidemics and antifungal resistance. This factor, which was first detected in 2009, has rapidly started to be seen globally, and there have been cases detected in our country in recent years. However, much remains unknown about this current global public health pathogen. In
KARAAYVAZ, Serhat, ALKAN, Sevil
openaire +1 more source
Microorganisms
Candida auris (C. auris) is an emerging multidrug-resistant fungal pathogen recognized by the World Health Organization (WHO) as a critical global health threat.
Christine Hsu, M. Yassin
semanticscholar +1 more source
Candida auris (C. auris) is an emerging multidrug-resistant fungal pathogen recognized by the World Health Organization (WHO) as a critical global health threat.
Christine Hsu, M. Yassin
semanticscholar +1 more source